Serotype distribution and drug resistance in Streptococcus pneumoniae, Palestinian Territories

Area of Science:

• Microbiology
• Pediatrics
• Epidemiology

Background:

• Streptococcus pneumoniae causes serious infections in children.
• Antimicrobial drug resistance is a growing global health concern.
• Understanding serotype distribution and resistance is crucial for public health interventions.

Purpose of the Study:

• To determine the antimicrobial drug resistance patterns of Streptococcus pneumoniae serotypes.
• To assess the potential impact of pneumococcal conjugate vaccines (PCVs) on preventable bacteremia cases.
• To identify the most drug-resistant serotypes circulating before widespread vaccination.

Main Methods:

• Analysis of Streptococcus pneumoniae isolates from blood cultures of sick children.
• Identification of serotypes causing bacteremia.
• Assessment of antimicrobial drug resistance profiles.
• Calculation of preventable bacteremia cases by PCVs based on serotype data.

Main Results:

• 120 Streptococcus pneumoniae serotypes were isolated from blood cultures.
• Pneumococcal conjugate vaccines could have potentially prevented 50.8%, 73.3%, and 80.8% of the identified bacteremia cases.
• Serotype 14 was identified as the most drug-resistant serotype among the isolates.

Conclusions:

• Significant antimicrobial drug resistance exists in Streptococcus pneumoniae serotypes.
• Pneumococcal conjugate vaccines demonstrate high potential for preventing childhood bacteremia caused by prevalent serotypes.
• Targeted surveillance and vaccination strategies are essential for controlling pneumococcal disease and resistance.